Published within
|«
«
|
...
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
CommentWire
|
Alliance & Leicester is considered to be a prime target for a takeover bid. Recent reports suggest that Abbey National is one interested predator. This may be the start of a new round of domestic consolidation in the UK retail banking sector. However, the major players are likely to miss out for regulatory reasons.
Published By Datamonitor
|
08 Jan 2002 |
|
CommentWire
|
Following A&P's Q2 loss of $144.7 million, the company is turning to budget-conscious shoppers to boost flagging sales. Its new Food Basics 'mini-supermarkets' take their concept from the increasingly popular dollar stores. However, Food Basics will only pose competition for the likes of Wal-Mart if A&P can maintain low prices and consistent product availability.
Published By Datamonitor
|
25 Oct 2002 |
|
Expert View
|
A recent consumer survey has shown that celebrity endorsements are one of the least trusted means of conveying product information, only just faring better than door-dropped leaflets. This is bad news for advertising agencies, which have been devoting increased energy to signing up everyone from bona fide A-list stars to Z-list reality show contestants to help sell products and services.
Published By Datamonitor
|
21 Jul 2006 |
|
CommentWire
|
The AA's partnership with Shoosmiths will allow it to compete with RAC's blossoming legal services division and capitalize on new opportunities in the sector. The services group's timing is appropriate, as regulatory changes in the law profession are likely to see a raft of familiar retail brands offering legal services. Like RAC, the AA is well placed at the vanguard of this shift.
Published By Datamonitor
|
21 Apr 2005 |
|
CommentWire
|
In a move to tackle the costs associated with credit hire, AA/Saga plans to bring its arrangements in-house. Credit hire costs are a major source of claims inflation for motor insurers, and bringing credit hire in-house could generate a lucrative side line, while also giving it greater control over a key driver in claims costs.
Published By Datamonitor
|
16 Jul 2009 |
|
CommentWire
|
After its recent acquisition by private equity houses CVC and Permira, the AA has announced a major restructuring including an exit from the car servicing business and cutbacks of up to 1,300 jobs. The moves will create a more efficient, streamlined and profitable company.
Published By Datamonitor
|
11 Oct 2004 |
|
Expert View
|
In the wake of Imitrex's and Topamax's patent expiries, announcements at this year's American Academy of Neurology meeting focused firmly on the next major breakthroughs for the acute and prophylactic migraine markets. Pooled data for candidates from Allergan and Merck & Co demonstrated impressive potential, suggesting renewed hope for sufferers.
Published By Datamonitor
|
20 Apr 2010 |
|
Expert View
|
A number of leading drug makers used this year's meeting of the American Academy of Neurology to present new data for promising pipeline candidates. Despite promising results, however, Datamonitor believes that the epilepsy drugs will struggle to find their place in the market. Moreover, the positive Phase II data for Baxter's potential Alzheimer's therapy Gammagard do not guarantee later success.
Published By Datamonitor
|
20 Apr 2010 |
|
Expert View
|
Datamonitor attended this year's American Academy of Neurology conference, where developments in multiple sclerosis took precedence for the third consecutive year. Both Novartis and Merck KGaA presented new data for their pipeline candidates, while Acorda used the meeting as a platform to share data for its symptomatic treatment Ampyra, which was recently approved by the FDA.
Published By Datamonitor
|
20 Apr 2010 |
|
Expert View
|
Datamonitor recently attended the 63rd American Academy of Neurology Annual Meeting in Honolulu, Hawaii, held over April 9-16, 2011. For another year running, developments in multiple sclerosis (MS) treatment research dominated proceedings. Below are the highlights of the conference's coverage of new multiple sclerosis drugs.
Published By Datamonitor
|
03 May 2011 |
|
|«
«
|
...
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.